Tejara Capital
Latest statistics and disclosures from Tejara Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ROIV, GLNG, TEVA, NBR, NEM, and represent 28.11% of Tejara Capital's stock portfolio.
- Added to shares of these 10 stocks: ROIV (+$20M), NEM (+$9.6M), LBTYA (+$9.4M), NBR (+$6.5M), HRTX (+$5.4M), FCX (+$5.2M), STNG (+$5.1M), SCPH, RIG, GDXJ.
- Started 15 new stock positions in NEM, AEM, NXE, ANIP, LBTYA, DOLE, GDXJ, CRK, OVID, SSYS. FCX, RIG, FRO, INSW, PAA.
- Reduced shares in these 10 stocks: C (-$16M), CCJ (-$7.6M), BTU, COLL, CEIX, HTZ, AGNC, FLR, FIP, VAL.
- Sold out of its positions in AA, AMRX, FLR, HTZ, Lilly Eli & Co option, PTVE, PTON, METCB, METC, VAPO. RNW, VAL.
- Tejara Capital was a net buyer of stock by $52M.
- Tejara Capital has $239M in assets under management (AUM), dropping by 35.33%.
- Central Index Key (CIK): 0001879713
Tip: Access up to 7 years of quarterly data
Positions held by Tejara Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Tejara Capital
Tejara Capital holds 67 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Roivant Sciences SHS (ROIV) | 10.0 | $24M | +495% | 2.1M | 11.23 |
|
| Golar Lng SHS (GLNG) | 4.9 | $12M | 508k | 22.99 |
|
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 4.6 | $11M | +28% | 1.1M | 10.44 |
|
| Nabors Industries SHS (NBR) | 4.5 | $11M | +146% | 133k | 81.63 |
|
| Newmont Mining Corporation (NEM) | 4.0 | $9.6M | NEW | 231k | 41.39 |
|
| Liberty Global Com Cl A (LBTYA) | 3.9 | $9.4M | NEW | 530k | 17.77 |
|
| Borr Drilling SHS (BORR) | 3.9 | $9.3M | +3% | 1.3M | 7.36 |
|
| Scorpio Tankers SHS (STNG) | 3.8 | $9.2M | +124% | 151k | 60.80 |
|
| Heron Therapeutics (HRTX) | 3.8 | $9.0M | +150% | 5.3M | 1.70 |
|
| Mereo Biopharma Group Spon Ads (MREO) | 3.6 | $8.6M | +15% | 3.7M | 2.31 |
|
| Nov (NOV) | 3.4 | $8.1M | +17% | 401k | 20.28 |
|
| Citigroup Com New (C) | 3.3 | $7.9M | -66% | 154k | 51.44 |
|
| Viatris (VTRS) | 2.8 | $6.6M | +31% | 613k | 10.83 |
|
| Geo Group Inc/the reit (GEO) | 2.6 | $6.1M | +37% | 563k | 10.83 |
|
| Bgc Group Cl A (BGC) | 2.5 | $5.9M | -11% | 816k | 7.22 |
|
| Orthofix Medical (OFIX) | 2.2 | $5.3M | +87% | 394k | 13.48 |
|
| Freeport-mcmoran CL B (FCX) | 2.2 | $5.2M | NEW | 122k | 42.57 |
|
| Rekor Systems (REKR) | 2.0 | $4.9M | +95% | 1.5M | 3.33 |
|
| Scpharmaceuticals (SCPH) | 2.0 | $4.8M | +647% | 758k | 6.27 |
|
| Forum Energy Technologies In (FET) | 1.9 | $4.6M | 209k | 22.17 |
|
|
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.8 | $4.3M | -51% | 141k | 30.78 |
|
| Transocean Reg Shs (RIG) | 1.6 | $3.9M | NEW | 615k | 6.35 |
|
| Noble Corp Ord Shs A (NE) | 1.6 | $3.9M | +265% | 80k | 48.16 |
|
| Peabody Energy (BTU) | 1.5 | $3.7M | -56% | 151k | 24.32 |
|
| Arcutis Biotherapeutics (ARQT) | 1.5 | $3.6M | +259% | 1.1M | 3.23 |
|
| Vaneck Etf Trust Junior Gold Mine (GDXJ) | 1.2 | $2.9M | NEW | 77k | 37.91 |
|
| ardmore Shipping (ASC) | 1.1 | $2.7M | +115% | 194k | 14.09 |
|
| Zymeworks Del (ZYME) | 1.1 | $2.7M | -11% | 256k | 10.39 |
|
| Schweitzer-Mauduit International (MATV) | 1.0 | $2.5M | 163k | 15.31 |
|
|
| Sociedad Quimica Y Minera De Spon Adr Ser B (SQM) | 1.0 | $2.3M | +160% | 39k | 60.22 |
|
| Consol Energy (CEIX) | 0.9 | $2.2M | -60% | 22k | 100.53 |
|
| Kenvue (KVUE) | 0.9 | $2.0M | -24% | 95k | 21.53 |
|
| Nexgen Energy (NXE) | 0.8 | $2.0M | NEW | 288k | 7.00 |
|
| Oportun Finl Corp (OPRT) | 0.8 | $1.8M | -7% | 466k | 3.91 |
|
| Telesat Corp Cl A & Cl B Shs (TSAT) | 0.7 | $1.8M | +20% | 168k | 10.43 |
|
| Denison Mines Corp (DNN) | 0.7 | $1.7M | +53% | 972k | 1.77 |
|
| Trevi Therapeutics (TRVI) | 0.7 | $1.7M | +604% | 1.3M | 1.34 |
|
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.7 | $1.7M | +171% | 95k | 17.54 |
|
| Mosaic (MOS) | 0.7 | $1.6M | -10% | 44k | 35.73 |
|
| Independence Contract Drilli (ICD) | 0.5 | $1.3M | +21% | 535k | 2.45 |
|
| Biosante Pharmaceuticals (ANIP) | 0.5 | $1.3M | NEW | 23k | 55.14 |
|
| International Seaways (INSW) | 0.5 | $1.2M | NEW | 27k | 45.48 |
|
| Stratasys SHS (SSYS) | 0.5 | $1.1M | NEW | 79k | 14.28 |
|
| Agnico (AEM) | 0.5 | $1.1M | NEW | 21k | 54.85 |
|
| Agnc Invt Corp Com reit (AGNC) | 0.5 | $1.1M | -68% | 111k | 9.81 |
|
| Sutro Biopharma (STRO) | 0.4 | $974k | +155% | 227k | 4.29 |
|
| Cardiol Therapeutics Com Cl A (CRDL) | 0.4 | $942k | +73% | 1.1M | 0.84 |
|
| Therapeuticsmd Com New (TXMD) | 0.4 | $904k | +8% | 402k | 2.25 |
|
| Karyopharm Therapeutics (KPTI) | 0.4 | $892k | -4% | 1.0M | 0.86 |
|
| Xperi Common Stock (XPER) | 0.4 | $837k | 76k | 11.02 |
|
|
| Frontline (FRO) | 0.3 | $818k | NEW | 41k | 20.05 |
|
| Dole Ord Shs (DOLE) | 0.3 | $651k | NEW | 53k | 12.29 |
|
| Torm Shs Cl A (TRMD) | 0.3 | $608k | -33% | 20k | 30.41 |
|
| Chimerix (CMRX) | 0.2 | $529k | +47% | 550k | 0.96 |
|
| Arbutus Biopharma (ABUS) | 0.2 | $450k | 180k | 2.50 |
|
|
| Cameco Corporation (CCJ) | 0.2 | $431k | -94% | 10k | 43.10 |
|
| Atai Life Sciences Nv SHS (ATAI) | 0.2 | $409k | 290k | 1.41 |
|
|
| Silverback Therapeutics (SPRY) | 0.2 | $404k | -28% | 74k | 5.48 |
|
| Comstock Resources (CRK) | 0.2 | $360k | NEW | 41k | 8.85 |
|
| Glatfelter (GLT) | 0.1 | $335k | -28% | 173k | 1.94 |
|
| Vincerx Pharma Com New (VINC) | 0.1 | $275k | 233k | 1.18 |
|
|
| Precision Biosciences Ord | 0.1 | $271k | +86% | 743k | 0.36 |
|
| Ovid Therapeutics (OVID) | 0.1 | $236k | NEW | 73k | 3.22 |
|
| Renalytix Ads (RNLX) | 0.1 | $156k | 400k | 0.39 |
|
|
| Ftai Infrastructure Common Stock (FIP) | 0.1 | $134k | -93% | 35k | 3.89 |
|
| Accelerate Diagnostics Com New (AXDX) | 0.0 | $53k | 14k | 3.92 |
|
|
| Plains All Amern Pipeline L Unit Ltd Partn (PAA) | 0.0 | $1.6k | NEW | 39k | 0.04 |
|
Past Filings by Tejara Capital
SEC 13F filings are viewable for Tejara Capital going back to 2022
- Tejara Capital 2023 Q4 filed Feb. 12, 2024
- Tejara Capital 2023 Q3 restated filed Nov. 15, 2023
- Tejara Capital 2023 Q2 filed Aug. 11, 2023
- Tejara Capital 2023 Q1 filed May 12, 2023
- Tejara Capital 2022 Q4 restated filed Feb. 15, 2023
- Tejara Capital 2022 Q4 filed Feb. 13, 2023